What is the management of metabolic acidosis post plasmapheresis (plasma exchange)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Metabolic Acidosis Post-Plasmapheresis

Monitor electrolytes serially during plasmapheresis and treat hyperchloremic metabolic acidosis with intravenous sodium bicarbonate to achieve serum bicarbonate ≥22 mmol/L, particularly in patients with impaired renal function. 1, 2, 3

Mechanism and Risk Factors

Hyperchloremic metabolic acidosis develops after plasmapheresis due to administration of large volumes of albumin replacement fluid containing high chloride concentrations (typically 132 mmol/L). 3

High-Risk Populations

  • Patients with impaired renal function are at highest risk for severe metabolic acidosis, as they cannot adequately excrete the chloride load 3
  • Patients receiving multiple daily plasmapheresis sessions accumulate greater chloride burden 3
  • Those with pre-existing metabolic derangements require closer monitoring 1

Clinical Recognition

Presenting Symptoms

  • Gastrointestinal complaints (nausea, vomiting) 3
  • Muscle weakness 3
  • Symptoms may develop after 4 or more plasmapheresis treatments 3

Laboratory Findings

  • Serum bicarbonate <22 mmol/L (severe cases may drop to 11-12 mmol/L) 2, 3
  • Elevated chloride (>111 mmol/L) with normal or near-normal sodium 3
  • Normal total-to-ionized calcium ratio rules out citrate accumulation as the cause 3

Treatment Algorithm

Immediate Management

Administer intravenous sodium bicarbonate to achieve serum bicarbonate ≥22 mmol/L. 2, 4

Dosing Protocol

  • For severe acidosis (pH <7.20): Give 2-5 mEq/kg body weight IV over 4-8 hours 2, 4
  • Initial bolus in emergent situations: 44.6-100 mEq (one to two 50 mL vials) 4
  • Titrate based on arterial blood gas monitoring and clinical response 4

Preventive Strategies

Modify the plasmapheresis replacement fluid to prevent recurrence: 5

  • Use 3% albumin combined with cryoprecipitate instead of high-chloride albumin solutions 5
  • Consider fresh frozen plasma as partial replacement in select cases 6
  • Provide daily oral bicarbonate supplementation prophylactically in high-risk patients 3

Monitoring Requirements

Serial monitoring is essential throughout plasmapheresis treatment: 1, 2

  • Measure arterial blood gases and serum bicarbonate before each session 2, 4
  • Check electrolytes (sodium, chloride, potassium, calcium, magnesium, phosphate) daily 1, 2
  • Monitor for hemodynamic shifts and coagulation abnormalities 1

Critical Pitfall to Avoid

Do not attempt full correction of acidosis within the first 24 hours, as this may cause rebound alkalosis due to delayed ventilatory readjustment. 4 Target total CO2 content of approximately 20 mEq/L at end of first day, which typically corresponds to normal blood pH 4.

Special Considerations

Citrate vs. Chloride Acidosis

  • Citrate accumulation causes metabolic alkalosis, not acidosis, and presents with elevated total-to-ionized calcium ratio 5, 3
  • Hyperchloremic acidosis from albumin solutions shows normal calcium ratio 3
  • This distinction is critical for appropriate treatment selection 3

Renal Transplant Patients

Patients with transplant rejection receiving plasmapheresis face compounded risk due to both impaired renal function and need for multiple exchange sessions 3. These patients require:

  • More aggressive prophylactic bicarbonate supplementation 3
  • Consideration of alternative replacement fluids from the outset 5
  • Daily rather than every-other-day electrolyte monitoring 1

References

Guideline

Plasmapheresis in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metabolic Acidosis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metabolic alkalosis due to plasmapheresis.

The American journal of medicine, 1985

Research

[Plasmapheresis in haematology].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.